InvestorsHub Logo
Followers 13
Posts 1528
Boards Moderated 0
Alias Born 11/03/2008

Re: None

Tuesday, 06/30/2020 10:05:38 AM

Tuesday, June 30, 2020 10:05:38 AM

Post# of 403039
Nasdaq's $1.2 trln biotech index draws Europe's COVID drug hunters
https://www.reuters.com/article/health-coronavirus-nasdaq-biotech-idUSL8N2E64SH
Spain’s Pharma Mar is looking at listing on New York’s Nasdaq market, joining a flurry of biotech companies aiming to tap investors’ voracious appetite for the sector as it tests one of its therapies to treat COVID-19.
Rather than listing directly, Pharma Mar is considering buying a rival in the United States, which could then provide a way to join the Nasdaq.”
“The company could use revenues of as much as $1 billion”
“We could buy an anti-tumor drug maker in the U.S. or a biotech in the U.S.

Possible suiter for a partnership as well I would think… Eh Leo? How bout' given them a call!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News